SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-315200
Filing Date
2019-12-16
Accepted
2019-12-16 16:15:32
Documents
3
Period of Report
2019-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d850035d8k.htm 8-K 19755
2 EX-99.1 d850035dex991.htm EX-99.1 11686
3 GRAPHIC g850035g1213193241724.jpg GRAPHIC 3163
  Complete submission text file 0001193125-19-315200.txt   37193
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 191287285
SIC: 2834 Pharmaceutical Preparations